StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report issued on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
The firm has a market capitalization of $833,000.00, a PE ratio of -0.01 and a beta of -0.90. Athersys has a 1-year low of $0.01 and a 1-year high of $1.99.
Athersys Company Profile
Further Reading
- Five stocks we like better than Athersys
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- When to Sell a Stock for Profit or Loss
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- What is a Special Dividend?
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.